Place of OTC analgesics and NSAIDs in osteoarthritis

Inflammopharmacology

Volumn 11, Issue 4-6, 2003, Pages 355-362

  Moore, Nicholas ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

NSAID; Osteoarthritis

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; COCODAMOL; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIACETYLRHEIN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL;

ADULT; AGED; CONFERENCE PAPER; CONSULTATION; DOSE RESPONSE; DRUG INDICATION; DRUG SAFETY; DRUG UTILIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS;

EID: 0842349098     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856003322699537     Document Type: Conference Paper

References (7)

1. Bombardier, C., Laine, L., Reicin, A., et al. (2000). Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group, N. Engl. J. Med. 343, 1520-1528.
2. Bradley, J. D., Brandt, K. D., Katz, B. P., et al. (1991). Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee, N. Engl. J. Med. 325, 87-91.
3. Henry, D., Lim, L. L., Garcia Rodriguez, L. A., et al. (1996). Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis, Br. Med. J. 312, 1563-1566.
4. Kurth, T., Glynn, R. J., Walker, A. M., et al. (2003). Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs, Circulation 108, 1191-1195.
5. Moore, N. (2001). Comment on 'Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use', Tramer et al., Pain 85 (2000) 169-182, Pain 91, 401-402.
6. Silverstein, F. E., Faich, G., Goldstein, J. L., et al. (2000). Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study, J. Am. Med. Ass. 284, 1247-1255.
7. Tramer, M. R., Moore, R. A., Reynolds, D. J., et al. (2000). Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use, Pain 85, 169-182.